NASDAQ:NPCE

Neuropace Stock Insider Trading

Healthcare > Medical - Devices

Buy NPCE

*Your capital is at risk

$15.37

-0.260 (-1.66%)

At Close: Jun 22, 2026

NeuroPace Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 31.94. In total, the insiders bought 577.81K and sold 57.96K NPCE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	31.94
● Buy	577.81K shares
● Sell	57.96K shares
78% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence May 15, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 31.94. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (78% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 19, 2026 Buy	Common Stock A-Award	Fischer Frank M Director	Director	1 467 Value: $22.9K
Jun 19, 2026 Buy	Common Stock A-Award	Geiger Uri Director	Director	789 Value: $12.3K
Jun 19, 2026 Buy	Common Stock A-Award	Kumar Rakhi Director	Director	989 Value: $15.5K
Jun 05, 2026 Buy	Common Stock A-Award	Andrade Lisa Director	Director	2 890 Value: $45.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Andrade Lisa Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Ryan Renee Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Common Stock A-Award	Kumar Rakhi Director	Director	2 890 Value: $45.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Geiger Uri Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Fischer Frank M Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Common Stock A-Award	Fischer Frank M Director	Director	2 890 Value: $45.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Huennekens R Scott Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Common Stock A-Award	Huennekens R Scott Director	Director	2 890 Value: $45.5K
Jun 05, 2026 Buy	Common Stock A-Award	Geiger Uri Director	Director	2 890 Value: $45.5K
Jun 05, 2026 Buy	Stock Option (Right to Buy) A-Award	Kumar Rakhi Director	Director	5 368 Value: $84.5K
Jun 05, 2026 Buy	Common Stock A-Award	Ryan Renee Director	Director	2 890 Value: $45.5K
Jun 03, 2026 Sell	Common Stock F-InKind	Becker Joel Chief Executive Officer	CEO / President	1 255 Value: $19.9K
May 27, 2026 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	358 Value: $6K
May 27, 2026 Sell	Common Stock F-InKind	Becker Joel Chief Executive Officer	CEO / President	1 126 Value: $19.2K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Becker Joel Chief Executive Officer	CEO / President	122 190 Value: $1.88M
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Morrell Martha Chief Medical Officer	Officer	14 550 Value: $223.5K
May 15, 2026 Buy	Common Stock A-Award	Morrell Martha Chief Medical Officer	Officer	5 460 Value: $83.9K
May 15, 2026 Buy	Common Stock A-Award	Williams Patrick F. Chief Financial Officer	C-Suite Officer	16 820 Value: $258.4K
May 15, 2026 Buy	Stock Option (Right to Buy) A-Award	Williams Patrick F. Chief Financial Officer	C-Suite Officer	44 800 Value: $688.1K
May 15, 2026 Buy	Common Stock A-Award	Becker Joel Chief Executive Officer	CEO / President	45 880 Value: $704.7K
Mar 24, 2026 Sell	Common Stock F-InKind	Morrell Martha Chief Medical Officer	Officer	1 341 Value: $17.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NEUROPACE, INC.

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...

Read Full Profile Here